AEPCX | AFCGX | AEPCX / AFCGX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 24 years | 6 years | - |
Gain YTD | 3.092 | 4.985 | 62% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 129B | 105M | 122,857% |
Annual Yield % from dividends | 0.81 | 1.28 | 63% |
Returns for 1 year | 7.72 | 12.71 | 61% |
Returns for 3 years | -19.28 | -18.94 | 102% |
Returns for 5 years | 4.26 | 23.44 | 18% |
Returns for 10 years | 16.83 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
DFAE | 25.59 | -0.02 | -0.08% |
Dimensional Emerging Core Equity Mkt ETF | |||
DVOL | 35.32 | -0.07 | -0.20% |
FirstTrustDorseyWrightMomt&LwVolatil ETF | |||
PFFL | 9.99 | -0.03 | -0.31% |
ETRACS 2xMonthly Pay Lvrgd Pref Stk ETN | |||
TUR | 35.14 | -0.33 | -0.93% |
iShares MSCI Turkey ETF | |||
PPH | 86.59 | -1.58 | -1.79% |
VanEck Pharmaceutical ETF |